Home › SinuSys Corp. To Support Clinical Study Of New Steroid-Eluting Spacer Designed To Improve Sinus Surgery Outcomes
 

Keywords :   


SinuSys Corp. To Support Clinical Study Of New Steroid-Eluting Spacer Designed To Improve Sinus Surgery Outcomes

2015-02-04 06:58:30| drugdiscoveryonline Home Page

SinuSys Corp., an innovative sinus health company, recently announced commencement of a new clinical trial studying its proprietary drug-eluting spacer infused with steroids for use following functional endoscopic sinus surgery (FESS)

Tags: support designed study improve

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
23.11
23.11 85
23.11DANCEWITHDRAGON2 811
23.11 N5000VSE
23.11EZY POWER EDIT6
23.11RR4
23.1126.5 HG
23.11VISSLA
More »